A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
Adenocarcinoma
/ therapy
Adult
Attitude of Health Personnel
Conservative Treatment
/ methods
Endometrial Hyperplasia
/ therapy
Endometrial Neoplasms
/ surgery
Female
Fertility Preservation
/ methods
France
Gonadotropin-Releasing Hormone
/ agonists
Gynecologic Surgical Procedures
/ methods
Gynecology
/ methods
Health Knowledge, Attitudes, Practice
Humans
Hysteroscopy
Intrauterine Devices, Medicated
Levonorgestrel
/ administration & dosage
Male
Middle Aged
Patient Education as Topic
Pregnancy
Progestins
/ therapeutic use
Reproductive Medicine
/ methods
Surveys and Questionnaires
Attitude
Endometrial atypical hyperplasia
Endometrial cancer
Fertility preservation
Fertility sparing
Knowledge
Journal
Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
17
02
2020
revised:
24
04
2020
accepted:
28
04
2020
pubmed:
18
5
2020
medline:
29
6
2021
entrez:
17
5
2020
Statut:
ppublish
Résumé
To describe knowledge and attitudes toward fertility preservation (FP) in patients with endometrial atypical hyperplasia or adenocarcinoma (EC/AH) among French gynecologists MATERIALS AND METHODS: A national survey among French gynaecologists: one questionnaire with one common part and two specific parts for gynecological surgeon (GS) or for specialists in reproductive medicine (SRM) was sent from April 2017 to April 2018. Knowledge and attitudes toward FP in EC/AH were evaluated with a "knowledge score" and an "attitudes score" using a four- or five-point Likert scale. One hundred forty physicians completed the survey (87 GS, 53 SRM). The knowledge score was low (59.3% medium/low), but it was significantly higher for GS compared to SRM. The better-known treatments were oral progestins and hysteroscopic resection. Among the participants treating EC/AH, 52.6% found it "difficult" to manage patients and 61.8% regretted the lack of official recommendations. Most physicians seemed to be uncomfortable/unsupportive with FP in EC/AH (57.2% "attitude score' below 11/20). There was a positive correlation between knowledge and attitude scores. GS "usually/always" give advice to patients about FP before EC/AH treatment. After maximum 3-6 months, 56.6% of SRM chose In Vitro Fecundation (IVF) to reduce time-to-pregnancy, with GnRH antagonist protocols (28%) or mild-stimulation (15.1%) to avoid hyperoestrogenism. Despite reassuring results in the literature, French gynecologists are uncomfortable with FP using EC/AH conservative management, which may be because of a lack of confidence in their knowledge. Specific guidelines are needed to help physicians manage these young patients and their fertility.
Identifiants
pubmed: 32416273
pii: S2468-7847(20)30137-9
doi: 10.1016/j.jogoh.2020.101794
pii:
doi:
Substances chimiques
Progestins
0
Gonadotropin-Releasing Hormone
33515-09-2
Levonorgestrel
5W7SIA7YZW
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101794Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.